Nerve Cuff approved for use in US DoD and VA hospitals
Filed with ASX · · 3 pages · English
ReNerve Limited (ASX, "ReNerve" or "the Company"), a leading Australian medical device innovator focused on solutions for peripheral nerve injury (PNI), is pleased to announce that its NervAlign® Nerve Cuff has been approved for use across the US Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems, representing a significant endorsement of ReNerve’s NervAlign® nerve cuff techn
Earlier from Renerve
- ReNerve Clinical Study Expansion
- Q1 FY26 Activities Report and Appendix 4C
- ReNerve achieves first sales of amniotic tissue range
- Investor Roadshow Presentation
- Empliq Product Launch
Later from Renerve
- Trading Halt
- ReNerve completes $3.2m capital raising
- ReNerve AGM Presentation
- Broader approval received in Hong Kong for Nerve Cuff
- ReNerve receives approval in Malaysia
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve